Archives

Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose​Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose 

A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fight addiction itself. Researchers found that people taking these medications were less likely to develop substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and Read More

This new diabetes pill burns fat without the downsides of Ozempic​This new diabetes pill burns fat without the downsides of Ozempic 

Scientists have developed an experimental diabetes and obesity pill that works in a completely different way from drugs like Ozempic. Rather than reducing hunger, it activates metabolism in skeletal muscle, helping lower blood sugar and increase fat burning while preserving muscle mass. Early clinical results suggest the treatment is safe and well tolerated. ​Scientists have Read More

STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more​STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more 

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup Read More

Popular GLP-1 drug may slow down biological aging, analysis indicates​Popular GLP-1 drug may slow down biological aging, analysis indicates 

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have proposed that these drugs may also influence the biology of aging, but direct evidence in humans has remained limited. ​Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread Read More

GLP-1 agonists linked to significantly lower long-term risk of knee replacement​GLP-1 agonists linked to significantly lower long-term risk of knee replacement 

GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open-access journal Regional Anesthesia & Pain Medicine. ​GLP-1 receptor agonist drugs, used for the treatment Read More

AI helps accelerate breast cancer diagnosis for high-risk women​AI helps accelerate breast cancer diagnosis for high-risk women 

Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer. Now, researchers at UC San Francisco and UC Berkeley have found a way to help reduce the wait and the worry by using AI to quickly identify those who are most likely to have the disease. By triaging these patients, the AI-guided workflow takes women with abnormal scans through the diagnostic process—from imaging to evaluation and sometimes even biopsy—in a single day.

Omnipod Pod Recall; Afrezza OK’d for Kids 6 and Up; CVS to Cover Zepbound Again​Omnipod Pod Recall; Afrezza OK’d for Kids 6 and Up; CVS to Cover Zepbound Again 

(MedPage Today) — Insulet initiated a voluntary device correction of certain Omnipod pods due to a manufacturing defect that causes insulin to leak rather than being fully delivered into the body, the FDA alerted. This action is separate from… ​ (MedPage Today) — Insulet initiated a voluntary device correction of certain Omnipod pods due to Read More